Gene Therapy
-
{
- All
- News
- Videos
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
Biotech Firm MedTherapy Says It Can Cut Gene Therapy Production Time To One Day
A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has significantly shortened the process.
-
New One-Shot Gene Editing Therapy May Reduce Bad Cholesterol By 62%
A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62% after a single infusion in an early trial, raising hopes for a long-lasting treatment to reduce heart attack risk
-
Liver Health Breakthrough: New Study Reveals How Gut Bacteria Can Restore Ageing Livers
A new study published in Digestive Disease Week reveals that good gut bacteria could restore ageing liver tissue. Here is what the study found and why it matters for liver health therapies.
-
Do Men Get Breast Cancer? The Silent Risk Factors Most Males Ignore
The symptoms of male breast cancer can be subtle, but they should never be dismissed. The most common sign is a painless lump beneath the nipple.
-
Understanding Hemophilia: Doctor Explains Symptoms, Treatment And Daily Challenges
Hemophilia is a rare genetic bleeding disorder affecting clotting ability. Here are its symptoms, treatment options, and everyday challenges, highlighting how early diagnosis, modern therapies, and lifestyle care can improve quality of life.
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
Nick Jonas' Friend Maya Kibbel Dies Of Wilson's Disease At 30: Signs And Risks Of The Rare Disease Explained
Nick Jonas lost his friend Maya Kibbel to Wilson's disease. Here is how the rare genetic disorder can manifest in the human body, along with the available treatment options.
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
FDA Push For Fake Brain Surgery Trial Spurs Ethical Concerns
The FDA's request, intended to conclusively determine the therapy's potency, has raised concerns the trial would be both unethical and impractical.
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
New Research On Gene Editing Therapy May Cut Cholesterol, Triglycerides By Half
Melbourne, Nov 10 (IANS) Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol and triglycerides in people with difficult-to-treat lipid disorders.
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
Biotech Firm MedTherapy Says It Can Cut Gene Therapy Production Time To One Day
A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has significantly shortened the process.
-
New One-Shot Gene Editing Therapy May Reduce Bad Cholesterol By 62%
A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62% after a single infusion in an early trial, raising hopes for a long-lasting treatment to reduce heart attack risk
-
Liver Health Breakthrough: New Study Reveals How Gut Bacteria Can Restore Ageing Livers
A new study published in Digestive Disease Week reveals that good gut bacteria could restore ageing liver tissue. Here is what the study found and why it matters for liver health therapies.
-
Do Men Get Breast Cancer? The Silent Risk Factors Most Males Ignore
The symptoms of male breast cancer can be subtle, but they should never be dismissed. The most common sign is a painless lump beneath the nipple.
-
Understanding Hemophilia: Doctor Explains Symptoms, Treatment And Daily Challenges
Hemophilia is a rare genetic bleeding disorder affecting clotting ability. Here are its symptoms, treatment options, and everyday challenges, highlighting how early diagnosis, modern therapies, and lifestyle care can improve quality of life.
-
A New Gene Therapy May Restore Hearing In Weeks, Give People Born Deaf A Chance To Hear Again
The treatment targets a specific type of inherited deafness caused by mutations in a gene called OTOF.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
Nick Jonas' Friend Maya Kibbel Dies Of Wilson's Disease At 30: Signs And Risks Of The Rare Disease Explained
Nick Jonas lost his friend Maya Kibbel to Wilson's disease. Here is how the rare genetic disorder can manifest in the human body, along with the available treatment options.
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
FDA Push For Fake Brain Surgery Trial Spurs Ethical Concerns
The FDA's request, intended to conclusively determine the therapy's potency, has raised concerns the trial would be both unethical and impractical.
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
India Launches 1st Indigenous, Low-Cost Gene Therapy For Sickle Cell Disease
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter.
-
New Research On Gene Editing Therapy May Cut Cholesterol, Triglycerides By Half
Melbourne, Nov 10 (IANS) Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol and triglycerides in people with difficult-to-treat lipid disorders.
